Publication Bias in Literature on Antidepressants for Autism

0
205

Researchers at the University of Michigan reviewed published and unpublished trials of serotonin receptor inhibitors (SRI) for the treatment of autism spectrum disorders (ASD). The published literature showed a significant benefit of SRIs for ASD behaviors, but the researchers found significant evidence of publication bias in all analyses. When analyses were corrected for publication bias, the researchers found no significant benefit of SRIs for the treatment of ASD. Results will be published in Pediatrics.

Abstract → 

Related Item:
U.S. News

***

Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

Previous articleIncome Differentials Cause Mental Illness
Next articleFantasy Video Game Zaps Depression in Adolescents
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]

LEAVE A REPLY